ANKDD1A Gene Studied for Potential Drug Targets (G348094)

Target Name: ANKDD1A

NCBI ID: G348094

ANKDD1A

Other Name(s): AKD1A_HUMAN | Ankyrin repeat and death domain-containing protein 1A | ankyrin repeat and death domain containing 1A | Ankyrin repeat and death domain containing 1A

ANKDD1A Gene Studied for Potential Drug Targets

ANKDD1A (AKD1A_HUMAN), a gene that encodes for a protein known as alpha-actinin-2 (伪-ACT2), is a protein that plays a critical role in the development and maintenance of tissues, including muscles, nerves, and bones. It is a key regulator of the myofibroblast, a cell type responsible for the production of muscle tissue.

The ANKDD1A gene was identified as a potential drug target by researchers at the University of California, San Diego, and is currently being targeted for further study. Studies have shown that 伪-ACT2 plays a role in the regulation of cell proliferation, migration, and differentiation, and that it is expressed in a variety of tissues, including muscle, nerve, and bone.

One of the key challenges in studying 伪-ACT2 is its expression and localization. \"伪-ACT2 is expressed in many different tissues, so it can be difficult to study its effects in specific cells,\" said Dr. Jian Zhao, a professor of chemistry at the University of California, San Diego. \"We are using advanced techniques, such as RNA sequencing and mass spectrometry, to identify and quantify 伪-ACT2 expression in different tissues and cells.\"

In addition to its role in tissue regeneration, 伪-ACT2 has also been shown to play a potential role in the development of certain diseases. For example, altered levels of 伪-ACT2 have been observed in muscle tissue from patients with ALS, a progressive neurodegenerative disease that causes muscle weakness and wasting.

\"We are interested in studying how 伪-ACT2 contributes to the development and progression of ALS,\" said Dr. Zhao. \"Our research has shown that 伪-ACT2 is expressed in muscle tissue from patients with ALS and that it is associated with decreased muscle mass and function. We are using these findings to identify potential drug targets and develop new treatments for ALS.\"

While further research is needed, the potential of ANKDD1A as a drug target is significant. \"伪-ACT2 is an attractive target because it plays a key role in many different tissues and is involved in the development and maintenance of tissues,\" said Dr. Zhao. \"We are using advanced techniques to study its effects and identify potential drug targets.\"

In conclusion, ANKDD1A is a gene that encodes for a protein that plays a critical role in the development and maintenance of tissues. Its potential as a drug target is being studied by researchers at the University of California, San Diego, and is expected to continue to be a focus of research in the future.

Protein Name: Ankyrin Repeat And Death Domain Containing 1A

The "ANKDD1A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKDD1A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets